Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

Update Il y a 4 ans
Reference: NCT02452931

Woman and Man

Extract

This study determines the effectiveness of leuprolide acetate 45 mg for injectable suspension for treatment of children with Central Precocious Puberty.


Inclusion criteria

  • Precocious Puberty, Central


Links